GO
Loading...

Medicine

More

  • CENTERS FOR DISEASE CONTROL SETS 7 PM ET NEWS CONFERENCE, HAVING PROMISED TO ISSUE NEW EBOLA GUIDELINES.

  • SAN FRANCISCO, Oct 20- Microsoft Corp will provide free cloud-computing and research applications to qualified medical researchers working on the Ebola virus, the software company's chief executive said on Monday. Azure is the name of Microsoft's cloud-computing platform, essentially a group of datacenters that allow users to access large amounts of...

  • Oct 20- BioMerieux SA is working with U.S. health regulators to determine if its test to screen for bio threats could be used to detect the Ebola virus, spokeswoman Suzanne Jones said. Since the system was solely developed for environmental surveillance, it is necessary for BioMerieux to show the U.S. Food and Drug Administration evidence that the test could be...

  • DALLAS, Oct 20- The United States is issuing new protocols for health workers treating Ebola patients and a rapid-response military medical team prepared to start training, even as 43 people being monitored for the virus were declared risk free. The government's new guidelines, which a top health official said could come out as soon as Monday, were expected to...

  • NEW YORK, Oct 20- U.S. "Both the Ebola scare and the expansion of ISIS have added jitters to the market and fear bids into the bond market," said Larry Milstein, head of government and agency trading at R.W. Pressprich& Co. in New York. "We feel the earliest is fourth quarter of next year when the Fed will take any action on rates," said Sean Simko, head of fixed-income...

  • DALLAS, Oct 20- Weeks of worry about Ebola infection ended on Monday for several dozen people who came off watch lists in the United States, but more than 260 others were still being monitored for symptoms as the U.S. government ramped up its response to the virus. In Texas, 43 people who had contact with Liberian Thomas Eric Duncan, the first person diagnosed with the...

  • White House halts funding on risky flu studies Monday, 20 Oct 2014 | 1:35 PM ET

    CHICAGO, Oct 20- The White House has temporarily stopped funding new research involving the flu and other. The U.S. government said it will pause funding for any new studies that include gain-of-function experiments involving flu, SARS and the Middle East Respiratory Syndrome or MERS viruses, the White House said in a statement posted on Friday.

  • DALLAS, Oct 20- Weeks of worry about Ebola infection ended on Monday for several dozen people who came off watch lists in the United States, but 120 others were still being monitored for symptoms as the U.S. government ramped up its response to the virus. Forty-three people who had contact with Liberian Thomas Eric Duncan, the first person diagnosed with the...

  • DALLAS, Oct 20- Weeks of worry about Ebola infection ended for dozens of people who came off watch lists in the United States on Monday, but scores were still being monitored after potential exposure to the virus, Texas health officials said. Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with the disease in the United...

  • DALLAS, Oct 20- Weeks of worries about a possible Ebola infection ended for dozens of people on watch lists in the United States on Monday but scores were still being monitored after potential exposure to the virus, Texas health officials said. Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with the disease in the United...

  • EU seeks $1.27 billion in Ebola aid for W. Africa Monday, 20 Oct 2014 | 5:55 AM ET

    LUXEMBOURG— The European Union committed itself Monday to step up efforts toward getting 1 billion euros in aid to fight Ebola in West Africa and rejected the idea of halting direct flights coming from the region. So far, the overall anti-Ebola total for the EU, including EU national contributions, stands at 500 million euros, with Britain contributing 160...

  • Urgent-care clinics ill-equipped to treat Ebola Monday, 20 Oct 2014 | 1:10 AM ET

    When a Dallas County sheriff's deputy who had entered the apartment of the first patient to die from Ebola in the U.S. started feeling ill himself, he didn't rush to the nearest hospital. So did a man who recently traveled to West Africa and was complaining of flu-like symptoms, prompting the suburban Boston urgent-care practice where he went to briefly shut down...

  • China gives $6 million for food in Ebola countries Monday, 20 Oct 2014 | 1:00 AM ET

    BEIJING— China has donated $6 million to help stave off food shortages in the three African countries worst affected by the Ebola virus, the World Food Program announced Monday, part of Beijing's growing assistance to a continent where its companies have become major investors. With the world's second-largest economy and a permanent seat on the U.N. Security...

  • Anti-abuse label approved for painkiller Embeda Friday, 17 Oct 2014 | 7:35 PM ET

    The FDA said Friday that Pfizer Inc.' s Embeda can have labeling indicating that it has properties expected to reduce abuse of the drug when it is crushed and taken orally or snorted. The FDA has been under intense public pressure to combat the national epidemic of prescription opioid abuse. Embeda is the third extended-release opioid to be approved with...

  • Ebola causing some people to change travel plans Friday, 17 Oct 2014 | 6:23 PM ET

    The virus has killed more than 4,500 in West Africa since the current outbreak began several months ago. Several people who contracted the disease there have been treated in the United States, but only three cases have been diagnosed in the U.S., all in Dallas. Still, Ebola fear increased when officials disclosed that a nurse tested positive for the virus just over...

  • Chimerix gets FDA OK to test drug for Ebola Friday, 17 Oct 2014 | 10:54 AM ET

    Chimerix Inc. said Thursday that it has received FDA clearance to proceed with a trial examining the safety and effectiveness of its brincidofovir tablets in patients who have the virus. Chimerix did not immediately return requests for comment. Chimerix is working with the U.S. Department of Defense on developing the drug as a treatment against smallpox.

  • Ahead of the Bell: Sarepta Therapeutics climbs Friday, 17 Oct 2014 | 7:39 AM ET

    Shares of Sarepta Therapeutics jumped 11 percent before the opening bell Friday after the drug developer said its potential Ebola treatment generated no safety concerns in early-stage human testing. The Cambridge, Massachusetts, company said Thursday that results from its study on healthy adult volunteers will be published in next month's issue of the...

  • Ebola hearing on Capitol Hill     Thursday, 16 Oct 2014 | 1:14 PM ET

    CNBC's Meg Tirrell provides the latest details on the Ebola hearing taking place on Capitol Hill.

  • A nurse from the Texas Health Presbyterian Hospital spoke to the Today Show's Matt Lauer about the protocol in handling Ebola. Dr. Alexander Garza of Saint Louis University, provides perspective.

  • Giuliani's view of Ebola containment     Thursday, 16 Oct 2014 | 11:43 AM ET

    Former New York City Mayor Rudy Giuliani discusses the protocols in place to contain Ebola.